SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Montana Wildhack who wrote (7643)8/23/2001 9:14:38 PM
From: Mark Bartlett  Respond to of 14101
 
Wolf,

<<laywers>>

That certainly did not take long.

MB



To: Montana Wildhack who wrote (7643)8/23/2001 11:54:47 PM
From: Joe Krupa  Read Replies (2) | Respond to of 14101
 
Wolf,

"Here come the lawyers"

Exactly to my point on SH today, that this issue is not going to go away soon. This could get real ugly over the next few months.

Though I would love to see Pennsaid approved by the FDA tomorrow, the climate will be prime anytime over the next 6 months for a new entrant . . . say, perhaps . . . one with no side effects and more efficacy.

"Pennsaid works and works well."

Heck, why not a new tag line?

"Pennsaid Saves!"

joe



To: Montana Wildhack who wrote (7643)8/26/2001 9:00:42 PM
From: Cal Gary  Read Replies (1) | Respond to of 14101
 
Fellow DMX Citizens,

What is the probability of a Canadian approval before an EU approval?

Tuesday marks the anniversary of HC rejection and the 315th day since Phase III (c) resubmission to HC. So we are in the overtime period with HC again.

September 4 marks 60 days since the recalibrated EU date for objections. October 4th, of course, marks the 90th day.

Pennsaid, Works and Works NICE.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News